PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
32293671-2	2020	Here, we report the clinical, biochemical, and molecular features of seven patients from four families with GALNT2-congenital disorder of glycosylation (GALNT2-CDG), an O-linked glycosylation disorder.	-cdg	159-163	polypeptide N-acetylgalactosaminyltransferase 2	Homo sapiens	108-114	
32293671-6	2020	Patients with GALNT2-CDG generally exhibit a syndrome characterized by global developmental delay, intellectual disability with language deficit, autistic features, behavioural abnormalities, epilepsy, chronic insomnia, white matter changes on brain MRI, dysmorphic features, decreased stature, and decreased high density lipoprotein cholesterol levels.	Cholesterol	334-345	polypeptide N-acetylgalactosaminyltransferase 2	Homo sapiens	14-20